From Opexa Tries a Personalized Cell Therapy Against Last, Worst Stage of MS:

Neil Warma, CEO of Opexa
Neil Warma, CEO of Opexa

Texas-based biotech company working on therapies for MS and autoimmune diseases. Image: Opexa Therapeutics.